We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Beckman Coulter Life Sciences to Produce Automated Cytometry Systems

By LabMedica International staff writers
Posted on 23 Apr 2012
Beckman Coulter Life Sciences (Indianapolis, IN, USA) has increased the range of its products by acquiring Blue Ocean Biomedical (Pembroke Pines, FL, USA), a manufacturer of a line of automated flow cytometry systems and associated reagents.

Beckman Coulter develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing. More...
Their diagnostic systems are found in hospitals and other critical care settings around the world and generate data used by physicians to diagnose disease, make treatment decisions, and monitor patients. In the research sector, their instruments have been applied to complex biological problems including causes of disease and potential new therapies or drugs.

Blue Ocean Biomedical specializes in the development of innovative, automated “load & go” cell-analysis systems for immune monitoring and related applications. Blue Ocean has optimized their systems to address needs for specific moderate-to-high-demand applications where test results are desired in less time, with greater efficiency and at substantially lower costs.

The CR Series Systems are among Blue Ocean Biomedical’s top-of-the-line research tools. This instrument is a fully integrated, fluorescence-based, cellular analysis research system dedicated to running standardized immune monitoring panels. The design of the CR Series takes full advantage of advanced technology to introduce a fresh, innovative approach to automating the process of immune panel testing. The CR Series combines automated sample preparation - “load & go”- sample processing and analysis in one compact instrument.

“This acquisition provides both immediate opportunity and long-term value,” said Scott Atkin, president of Beckman Coulter Life Sciences. “The simplification of customer workflows will be dramatic. We will be able to offer customers an extended line of market leading technology while expanding our reach within a key segment for flow cytometry.”

“Our team has developed a line of truly unique instrument systems: essentially, the world’s first ‘load & go’ flow cytometers,” said Mike Brochu, CEO of Blue Ocean Biomedical. “With its history of leadership and innovation in this field, Beckman Coulter has all the resources and technology needed to build on this platform and future systems for years to come.”

The CR systems and reagents are currently not available in the US, and are for distribution in the European Union only.

Related Links:
Beckman Coulter Life Sciences
Blue Ocean Biomedical


New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automatic CLIA Analyzer
Shine i6000
New
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.